Drugs / lumbrokinase
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT07121569 | Jul 2024 → Mar 2025 | ischemic stroke | Universitas Sebelas Maret | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | lumbrokinase | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07121569 ↗ |
| Known as | DLBS1033 | “Patients with acute ischemic stroke who received oral lumbrokinase DLBS1033 (490 mg, DISOLF film-coated tablet, Dexa Medica, 2 tabs t.i.d.)” NCT07121569 ↗ |